SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000812796-04-000044
Filing Date
2004-12-14
Accepted
2004-12-13 18:04:37
Documents
3
Period of Report
2004-12-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 SEMBER AND MYRIANTHOPOULOS OFFICERS sember.htm 8-K 26332
2 PRESS RELEASE DEC. 10 - SEMBER - MYRIANTHOPOULOS pressrelease.htm EX-99.1 15561
3 SEMBER EMPLOYMENT AGREEMENT semberemployment.htm EX-10.1 57389
  Complete submission text file 0000812796-04-000044.txt   101426
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 041199787
SIC: 2834 Pharmaceutical Preparations